JP2012511506A5 - - Google Patents

Download PDF

Info

Publication number
JP2012511506A5
JP2012511506A5 JP2011539029A JP2011539029A JP2012511506A5 JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5 JP 2011539029 A JP2011539029 A JP 2011539029A JP 2011539029 A JP2011539029 A JP 2011539029A JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5
Authority
JP
Japan
Prior art keywords
human insulin
desb30
insulin
amino acid
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011539029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012511506A (ja
Filing date
Publication date
Priority claimed from PCT/EP2009/053017 external-priority patent/WO2009115469A1/en
Application filed filed Critical
Priority claimed from PCT/EP2009/066335 external-priority patent/WO2010066636A1/en
Publication of JP2012511506A publication Critical patent/JP2012511506A/ja
Publication of JP2012511506A5 publication Critical patent/JP2012511506A5/ja
Withdrawn legal-status Critical Current

Links

JP2011539029A 2008-12-09 2009-12-03 新規インスリンアナログ Withdrawn JP2012511506A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP08171086 2008-12-09
EP08171086.5 2008-12-09
EPPCT/EP2009/053017 2009-03-13
PCT/EP2009/053017 WO2009115469A1 (en) 2008-03-18 2009-03-13 Protease stabilized, acylated insulin analogues
EP09161014 2009-05-25
EP09161014.7 2009-05-25
EP09161232 2009-05-27
EP09161232.5 2009-05-27
PCT/EP2009/066335 WO2010066636A1 (en) 2008-12-09 2009-12-03 Novel insulin analogues

Publications (2)

Publication Number Publication Date
JP2012511506A JP2012511506A (ja) 2012-05-24
JP2012511506A5 true JP2012511506A5 (enExample) 2014-06-19

Family

ID=41651437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011539029A Withdrawn JP2012511506A (ja) 2008-12-09 2009-12-03 新規インスリンアナログ

Country Status (5)

Country Link
US (1) US20110294729A1 (enExample)
EP (1) EP2376531A1 (enExample)
JP (1) JP2012511506A (enExample)
CN (1) CN102245633A (enExample)
WO (1) WO2010066636A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2254906T3 (en) 2008-03-18 2017-01-23 Novo Nordisk As Protease-stabilized acylated insulin analogues
CN102947331B (zh) * 2010-06-23 2016-08-03 诺沃—诺迪斯克有限公司 包含额外的二硫键的胰岛素类似物
AU2011269000C1 (en) 2010-06-23 2015-10-08 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
EP2585483A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Human insulin containing additional disulfide bonds
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
EP2901154B1 (en) * 2012-09-25 2018-11-21 The Walter and Eliza Hall Institute of Medical Research Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain
US20140269611A1 (en) * 2013-03-14 2014-09-18 T-Mobile Usa, Inc. Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks
IL264330B2 (en) * 2016-07-22 2024-05-01 Univ Utah Res Found An insulin analog, pharmaceutical composition comprising it and its uses
HUE060149T2 (hu) 2016-12-16 2023-02-28 Novo Nordisk As Inzulint tartalmazó gyógyászati készítmények
CA3122636A1 (en) 2018-12-11 2020-06-18 Sanofi Insulin analogs having reduced insulin receptor binding affinity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616205B2 (en) * 1988-07-20 1991-10-24 Novo Nordisk A/S Human insulin analogs and preparations containing them
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
ATE120762T1 (de) * 1989-04-20 1995-04-15 Sinai School Medicine Hepatospezifische insulin-analoga.
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
JP2003518917A (ja) * 1999-05-19 2003-06-17 ゼンコー 糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質
US6746853B1 (en) * 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
ES2601839T3 (es) * 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
EP2254905B1 (en) * 2008-03-14 2016-12-14 Novo Nordisk A/S Protease-stabilized insulin analogues
DK2254906T3 (en) * 2008-03-18 2017-01-23 Novo Nordisk As Protease-stabilized acylated insulin analogues

Similar Documents

Publication Publication Date Title
JP2012511506A5 (enExample)
JP2018527288A5 (enExample)
WO2014071405A3 (en) Long-acting single-chain insulin analogues
WO2010014946A3 (en) Halogen-stabilized insulin
JP2013530974A5 (enExample)
EP2717918C0 (en) COMPOSITION FOR THE TREATMENT OF DIABETES COMPRISING A LONG-ACTING INSULIN CONJUGATE AND A LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE
JP2018505146A5 (enExample)
JP2014129355A5 (enExample)
JP2013533227A5 (enExample)
WO2009112583A3 (en) Protease-stabilized insulin analogues
EP2543727A4 (en) MODIFIED ANTIBODY COMPOSITION
MY167234A (en) Novel glucagon analogues
PH12012501135A1 (en) Insulin analogues with chlorinated amino acids
WO2015128403A3 (en) An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue
JP2013530702A5 (enExample)
NZ597676A (en) Crystalline anti-hTNFalpha antibodies
JP2017500289A5 (enExample)
HK1213483A1 (zh) Glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂
MX2013011175A (es) Analogos de glucagon novedosos.
JP2013542919A5 (enExample)
EP2570873A3 (en) Watch with shapeable strap
WO2010010551A3 (en) Angiopoietin derived peptides
WO2011072288A3 (en) Insulin analogues with chlorinated amino acids
WO2011143406A3 (en) Parathyroid hormone analogs and uses thereof
WO2016105545A3 (en) Insulin analogues with enhanced stabilized and reduced mitogenicity